As described for IGF2/H19, epigenetic changes at DLK1/GTL2 occur in human cancers.     ///    "However, these changes are not associated with DLK1 LOI highlighting differences in the imprinting control mechanisms operating in the IGF2-H19 and DLK1-GTL2 domains. "